Viewing Study NCT02429505


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2026-03-01 @ 6:02 AM
Study NCT ID: NCT02429505
Status: WITHDRAWN
Last Update Posted: 2020-08-28
First Post: 2015-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
Sponsor: Knight Therapeutics (USA) Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module